Upstate Active Clinical Trials Seeking Participants
Study title
Allogeneic Hematopoietic Stem Cell Transplanation for CLL, CML, AML, ALL, Myelodysplasia and Non-Hodgkin?s Lymphoma after Total Body Irradiation and Cyclophosphamide Conditioning or Cyclophosphamide and ATG Conditioning For Aplastic Anemia.
IRB number
3811F
What is the purpose of the study?
To provide allogeneic transplantation for patients with a matched related donor.
Who is eligible?
Diagnosis of ALL, CLL, CML, AML, Myelodyslasia and Non-Hodgkin's with a matched related donor, acceptable laboratory values, HIV negative, no serious or uncontrolled organ dysfunction.
What is involved if I participate?
- How long is the study?
Inpatient stay approximately 30 days, followed for lifetime. - Is transportation provided or reimbursed?
No - Is parking provided or reimbursed?
No - What tests and procedures are involved?
Detailed history & physical to determine eligibility, laboratory tests, x-rays/scans, as necessary, bone marrow biopsy & aspirate as necessary, laboratory tests during hospital admission, dental clearance prior to transplant.
Who is the doctor administering the study?
Teresa C. Gentile, M.D., Ph.D.
Where will the study take place?
SUNY Upstate Medical University,
Syracuse, NY
Over what time period is the study scheduled to run?
11/18/98 and continuing
Who can I contact for more information?
- Name: Joanne M. Chilton, CCRP
- Phone: (315) 464-8240
- Email: chiltonj@upstate.edu
- Fax: (315) 464-8274 or (315) 464-8289
If you are interested in this trial, please contact the study coordinator or investigator noted above.
